Leading the pharmaceutical industry in sustainability

Around the world, we continuously work to reduce our environmental impact, improve health and wellbeing of our communities, and lead the fight against antimicrobial resistance.

Read more

Meeting highest standards

Read more
Fill 1 Created with Sketch.
Media release

Centrient Pharmaceuticals to acquire Astral SteriTech, expanding its product portfolio with sterile injectable antibiotic finished dosage forms

Centrient Pharmaceuticals, the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the signing of an agreement for the acquisition of Astral SteriTech Private Limited, a leading international manufacturer specialised in sterile antibiotic injectable finished dosage forms. With the acquisition of Astral SteriTech, Centrient strengthens its position as the global business-to-business industry leader in beta-lactam antibiotics.

read more
News

Centrient Pharmaceuticals recieves 2020 Gold Sustainability Rating

read more
News

Our Sustainability Report 2019

read more

Here's why we think you should come work with us:

  • Make an impact
  • Build a winning career
  • Become part of a global network
Read more
2200

employees around the globe

150

years of innovation

75

years of antibiotics

14

locations

america

Close to customers everywhere

Our manufacturing sites and sales offices around the globe are the cornerstones of our customer and supplier relationships, providing on-the-ground support and ensuring security of supply

read more
europe